Eric R. Olson

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 620 Memorial Drive, Suite 300, Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric R. Olson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 6.66K $29.4K $4.42 Jul 17, 2023 Direct

Insider Reports Filed by Eric R. Olson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Jul 17, 2023 1 -$2.41K 4 Jul 18, 2023 Chief Scientific Officer
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2023 3 -$1.61K 4 Apr 4, 2023 Chief Scientific Officer
SYRS Syros Pharmaceuticals, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 Chief Scientific Officer
SYRS Syros Pharmaceuticals, Inc. Oct 6, 2022 2 $0 4 Oct 11, 2022 Chief Scientific Officer
SYRS Syros Pharmaceuticals, Inc. Apr 1, 2022 1 -$30.5K 4 Apr 4, 2022 Chief Scientific Officer
SYRS Syros Pharmaceuticals, Inc. Feb 15, 2022 3 $0 4 Feb 17, 2022 Chief Scientific Officer
SYRS Syros Pharmaceuticals, Inc. Jan 5, 2022 1 -$7.65K 4 Jan 6, 2022 Chief Scientific Officer
SYRS Syros Pharmaceuticals, Inc. Jul 1, 2021 1 -$6.46K 4 Jul 1, 2021 Chief Scientific Officer